R Segal1, C Zwaal2, E Green3, J R Tomasone4, A Loblaw5, T Petrella6. 1. Medical Oncology, The Ottawa Hospital, Ottawa. 2. McMaster University, Hamilton. 3. Canadian Partnership Against Cancer, Toronto. 4. Queen's University, Kingston. 5. Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Hospital, Toronto; and. 6. ncic Melanoma Clinical Trials Group, Sunnybrook Hospital, Toronto, ON.
Abstract
BACKGROUND: Development of this guideline was undertaken by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario's Program in Evidence-Based Care (pebc). The purpose of the guideline was to provide guidance for clinicians with respect to exercise for patients living with cancer, focusing on the benefits of specific types of exercise, recommendations about screening requirements for new referrals, and safety concerns. METHODS: Consistent with the pebc's standardized approach, a systematic search was conducted for existing guidelines, and systematic literature searches were performed in medline and embase for both systematic reviews and primary literature. Content and methodology experts performed an internal review, which was followed by an external review by targeted experts and intended users. RESULTS: The search identified three guidelines, eighteen systematic reviews, and twenty-nine randomized controlled trials with relevance to the topic. The present guideline provides recommendations for the duration, frequency, and intensity of exercise appropriate for people living with cancer. It also provides recommendations for pre-exercise assessment, safety concerns, and delivery models. CONCLUSIONS: There is sufficient evidence to show that exercise provides benefits in quality of life and muscular and aerobic fitness for people with cancer both during and after treatment, and that it does not cause harm. The present guideline is intended to support the Canadian Society for Exercise Physiology's Canadian physical activity guidelines. The recommendations are intended for clinicians and institutions treating cancer patients in Ontario, and for policymakers and program planners involved in the delivery of exercise programs for cancer patients.
BACKGROUND: Development of this guideline was undertaken by the Exercise for People with Cancer Guideline Development Group, a group organized by Cancer Care Ontario's Program in Evidence-Based Care (pebc). The purpose of the guideline was to provide guidance for clinicians with respect to exercise for patients living with cancer, focusing on the benefits of specific types of exercise, recommendations about screening requirements for new referrals, and safety concerns. METHODS: Consistent with the pebc's standardized approach, a systematic search was conducted for existing guidelines, and systematic literature searches were performed in medline and embase for both systematic reviews and primary literature. Content and methodology experts performed an internal review, which was followed by an external review by targeted experts and intended users. RESULTS: The search identified three guidelines, eighteen systematic reviews, and twenty-nine randomized controlled trials with relevance to the topic. The present guideline provides recommendations for the duration, frequency, and intensity of exercise appropriate for people living with cancer. It also provides recommendations for pre-exercise assessment, safety concerns, and delivery models. CONCLUSIONS: There is sufficient evidence to show that exercise provides benefits in quality of life and muscular and aerobic fitness for people with cancer both during and after treatment, and that it does not cause harm. The present guideline is intended to support the Canadian Society for Exercise Physiology's Canadian physical activity guidelines. The recommendations are intended for clinicians and institutions treating cancerpatients in Ontario, and for policymakers and program planners involved in the delivery of exercise programs for cancerpatients.
Authors: Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger Journal: CMAJ Date: 2010-07-05 Impact factor: 8.262
Authors: Daniel Santa Mina; M H Alibhai S; Andrew G Matthew; Crissa L Guglietti; Meysam Pirbaglou; John Trachtenberg; Paul Ritvo Journal: J Aging Phys Act Date: 2012-12-10 Impact factor: 1.961
Authors: Jos A Stigt; Steven M Uil; Susanne J H van Riesen; Frans J N A Simons; Monique Denekamp; Ghada M Shahin; Harry J M Groen Journal: J Thorac Oncol Date: 2013-02 Impact factor: 15.609
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Laura Q Rogers; Philip M Anton; Amanda Fogleman; Patricia Hopkins-Price; Steven Verhulst; Krishna Rao; James Malone; Randy Robbs; Kerry S Courneya; Parashar Nanavati; Sara Mansfield; K Thomas Robbins Journal: Head Neck Date: 2012-07-30 Impact factor: 3.147
Authors: Prue Cormie; Daniel A Galvão; Nigel Spry; David Joseph; Raphael Chee; Dennis R Taaffe; Suzanne K Chambers; Robert U Newton Journal: BJU Int Date: 2014-07-27 Impact factor: 5.588
Authors: M Carayol; P Bernard; J Boiché; F Riou; B Mercier; F Cousson-Gélie; A J Romain; C Delpierre; G Ninot Journal: Ann Oncol Date: 2012-10-05 Impact factor: 32.976
Authors: G Arbane; A Douiri; N Hart; N S Hopkinson; S Singh; C Speed; B Valladares; R Garrod Journal: Physiotherapy Date: 2014-02-12 Impact factor: 3.358
Authors: Daniel Y T Fong; Judy W C Ho; Bryant P H Hui; Antoinette M Lee; Duncan J Macfarlane; Sharron S K Leung; Ester Cerin; Wynnie Y Y Chan; Ivy P F Leung; Sharon H S Lam; Aliki J Taylor; Kar-keung Cheng Journal: BMJ Date: 2012-01-30
Authors: Hendrik Mugele; Nils Freitag; Jannik Wilhelmi; Yanxiang Yang; Sulin Cheng; Wilhelm Bloch; Moritz Schumann Journal: J Cancer Surviv Date: 2019-02-26 Impact factor: 4.442
Authors: D Santa Mina; D Au; J Brunet; J Jones; G Tomlinson; N Taback; D Field; A Berlingeri; H Bradley; D Howell Journal: Curr Oncol Date: 2017-10-25 Impact factor: 3.677
Authors: Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner Journal: Front Immunol Date: 2021-02-01 Impact factor: 7.561
Authors: Amy A Kirkham; Cheri L Van Patten; Karen A Gelmon; Donald C McKenzie; Alis Bonsignore; Kelcey A Bland; Kristin L Campbell Journal: Oncologist Date: 2017-10-05
Authors: Nicole L Stout; Justin C Brown; Anna L Schwartz; Timothy F Marshall; Anna M Campbell; Larissa Nekhlyudov; David S Zucker; Karen M Basen-Engquist; Grace Campbell; Jeffrey Meyerhardt; Andrea L Cheville; Kelley R Covington; Jennifer A Ligibel; Jonas M Sokolof; Kathryn H Schmitz; Catherine M Alfano Journal: Cancer Date: 2020-03-25 Impact factor: 6.860
Authors: D Santa Mina; C M Sabiston; D Au; A J Fong; L C Capozzi; D Langelier; M Chasen; J Chiarotto; J R Tomasone; J M Jones; E Chang; S N Culos-Reed Journal: Curr Oncol Date: 2018-04-30 Impact factor: 3.677